Literature DB >> 24036009

Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis.

Laurence Amiot1, Nicolas Vu2, Michel Rauch2, Annie L'Helgoualc'h2, Frédéric Chalmel2, Hugues Gascan3, Bruno Turlin4, Dominique Guyader5, Michel Samson2.   

Abstract

BACKGROUND & AIMS: Infection with hepatitis C virus is a worldwide health problem. An inadequate Th2 cytokine response promotes the fibrosis-cirrhosis fate. Immune-modulating molecules favoring a Th2 profile, such as HLA-G molecules of the HLA class Ib family, may play a role in chronic hepatitis. HLA-G contributes to the escape of tumors, and their involvement in viral infections has been increasingly described. The aim of this work was to study the expression of HLA-G in the liver, its cellular source and its regulation in cases of chronic C hepatitis.
METHODS: HLA-G cells in blocks of liver derived from patients infected with HCV were labeled by immunohistochemistry and enumerated. Double immunofluorescence allowed the identification of the cellular source. HLA-G secretion by a human mast cell line was quantified by ELISA after various stimulations. After treatment with IFN-α, real-time PCR was performed to determine the kinetics of cytokine expression profiles, followed by heat map clustering analysis.
RESULTS: The number of HLA-G+ cells was significantly associated with the area of fibrosis. For the first time, we identify the HLA-G+ cells as being mast cells. HLA-G secretion was significantly induced in human mast cells stimulated by IL-10 or interferons of class I. The transcriptome of the secretome of this cell line stimulated by IFN-α revealed that (i) the HLA-G gene is upregulated late, and that (ii) T lymphocytes and NK cells are recruited.
CONCLUSIONS: These findings suggest an autocrine loop in the genesis of HCV liver fibrosis, based on mast cells expressing HLA-G.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fibrosis; HBV; HCC; HCMV; HCV; HIV; HLA-G; HSC; Hepatitis C; IFN; IFN-α; IL; ILT; Immunoglobulin-like transcript receptors; Liver; MC; Mast cell; OSM; SCF; TGF-β; hepatic stellate cell; hepatitis B virus; hepatitis C virus; hepatocellular carcinoma; human cytomegalovirus; human immunodeficiency virus; interferon; interleukin; mast cell; oncostatin; stem cell factor; transforming growth factor β

Mesh:

Substances:

Year:  2013        PMID: 24036009     DOI: 10.1016/j.jhep.2013.09.006

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  25 in total

Review 1.  The emerging role of mast cells in liver disease.

Authors:  Veronica Jarido; Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Joanne Thomson; Kristen Stephenson; Heather Francis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-04       Impact factor: 4.052

2.  Delayed inflammatory and cell death responses are associated with reduced pathogenicity in Lujo virus-infected cynomolgus macaques.

Authors:  Angela L Rasmussen; Nicolas Tchitchek; David Safronetz; Victoria S Carter; Christopher M Williams; Elaine Haddock; Marcus J Korth; Heinz Feldmann; Michael G Katze
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

3.  High plasma levels of HLA-G are associated with low birth weight and with an increased risk of malaria in infancy.

Authors:  Ibrahim Sadissou; Tania d'Almeida; Gilles Cottrell; Adrian Luty; Irène Krawice-Radanne; Achille Massougbodji; Philippe Moreau; Kabirou Moutairou; André Garcia; Benoit Favier; Nathalie Rouas-Freiss; David Courtin
Journal:  Malar J       Date:  2014-08-12       Impact factor: 2.979

Review 4.  The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases.

Authors:  Fabrício C Dias; Erick C Castelli; Cristhianna V A Collares; Philippe Moreau; Eduardo A Donadi
Journal:  Front Immunol       Date:  2015-02-02       Impact factor: 7.561

Review 5.  HLA-G Molecules in Autoimmune Diseases and Infections.

Authors:  Roberta Rizzo; Daria Bortolotti; Silvia Bolzani; Enrico Fainardi
Journal:  Front Immunol       Date:  2014-11-18       Impact factor: 7.561

6.  AAV vector-meditated expression of HLA-G reduces injury-induced corneal vascularization, immune cell infiltration, and fibrosis.

Authors:  Matthew L Hirsch; Laura M Conatser; Sara M Smith; Jacklyn H Salmon; Jerry Wu; Nicholas E Buglak; Rich Davis; Brian C Gilger
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

Review 7.  Immunomodulatory properties of HLA-G in infectious diseases.

Authors:  Laurence Amiot; Nicolas Vu; Michel Samson
Journal:  J Immunol Res       Date:  2014-04-15       Impact factor: 4.818

8.  The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology.

Authors:  Vera Rebmann; Lisa König; Fabiola da Silva Nardi; Bettina Wagner; Luis Felipe Santos Manvailer; Peter A Horn
Journal:  Front Immunol       Date:  2016-05-04       Impact factor: 7.561

9.  Outcomes of Interferon/Ribavirin Therapy in Patients with HCV Defined by Expression of Plasma Soluble Human Leukocyte Antigen-G but Not IL-37.

Authors:  Shi-xiong Ding; Jian-bo Ma; Yao-ren Hu; Ai-rong Hu; Qiang Shen; Guo-shen Gao
Journal:  Med Sci Monit       Date:  2016-04-26

Review 10.  Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?

Authors:  Nicole B Crux; Shokrollah Elahi
Journal:  Front Immunol       Date:  2017-07-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.